Day-to-day management of the Cancer Center is nearly synonymous with day-to-day management of the City of Hope National Medical Center &Beckman Research Institute. Administration supports Cancer Center research by providing business administration functions (e.g., budgeting and accounting for shared resources, CCSG budgets, and other cancer research-related budgets;preparing productivity and other analyses);planning functions (e.g., strategic, facilities, recruitment, and capital);information systems functions (e.g., databases for CCSG-required data);general administrative support (e.g., committee and meeting management, seminar arrangements, data entry, word processing);and external relations (e.g., professional organizations, NCI staff, other cancer centers, and other academic institutions). Leading the effort to continue the automation of key infrastructure systems, center administration has played a pivotal role in enhancing the research environment. This includes the implementation of a new process management system for automation of both the scientific review and the human subjects review processes for clinical research protocols, the introduction of a LIMS system to many of the shared resources, and an ongoing project to install a common """"""""back-end"""""""" for all shared resource data collection and billing. In addition, the clinical research support structure has been greatly enhanced with the creation of centralized support systems, an updated Data and Safety Monitoring Plan and the creation of an independent clinical research auditing function. This request is for $204,294 for salary and benefits of 2.4 FTEs to support administrative functions (excluding clinical research support systems, which are in the Data and Safety Monitoring budget) and $22,894 for the Cancer Center's Seminar Series. This represents 8.5% of the total cost of administration.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
City of Hope/Beckman Research Institute
United States
Zip Code
Cao, Pengpeng; Mooney, Rachael; Tirughana, Revathiswari et al. (2017) Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors. Bioconjug Chem 28:1767-1776
Gu, Ying; Zhang, Jiawei; Ma, Xiaoxiao et al. (2017) Stabilization of the c-Myc Protein by CAMKII? Promotes T Cell Lymphoma. Cancer Cell 32:115-128.e7
Wittenberg, Elaine; Ferrell, Betty; Koczywas, Marianna et al. (2017) Pilot Study of a Communication Coaching Telephone Intervention for Lung Cancer Caregivers. Cancer Nurs :
Mohanty, Suchismita; Mohanty, Atish; Sandoval, Natalie et al. (2017) Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines. Leuk Lymphoma 58:676-688
Deng, Ruishu; Hurtz, Christian; Song, Qingxiao et al. (2017) Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease. Nat Commun 8:978
Yuan, Yuan; Vora, Nilesh; Sun, Can-Lan et al. (2017) Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast Cancer. Oncologist 22:1189-1196
Kortylewski, Marcin; Moreira, Dayson (2017) Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities. Cancer Immunol Immunother 66:979-988
He, Zhiheng; Ma, Jian; Wang, Ruiqing et al. (2017) A two-amino-acid substitution in the transcription factor ROR?t disrupts its function in TH17 differentiation but not in thymocyte development. Nat Immunol 18:1128-1138
Slavin, Thomas P; Neuhausen, Susan L; Nehoray, Bita et al. (2017) The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Fam Cancer :
Somlo, George; Frankel, Paul H; Arun, Banu K et al. (2017) Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083. Clin Cancer Res 23:4066-4076

Showing the most recent 10 out of 1277 publications